BRKR

Bruker Corporation

HALAL

Score: 84/100

stock

Is BRKR Halal?

Manufacturer of scientific instruments and analytical-measurement systems for research and life-science applications — a permissible scientific-instrumentation business, with leverage as the primary financial-screen consideration.

What You Should Know

Bruker Corporation is a publicly-traded designer and manufacturer of high-performance scientific instruments and analytical-and-diagnostic solutions, including magnetic-resonance (NMR), mass-spectrometry, X-ray, infrared-and-Raman, fluorescence-microscopy, and other analytical-measurement systems used in academic-research, pharmaceutical, biotechnology, applied-markets, and clinical-research settings. Scientific-instrument manufacturing, analytical-measurement-systems development, and life-science-research-tools are general-purpose engineered-equipment and research-tools activities that are unambiguously permissible at the activity level under standard Sharia methodology. The financial screen is the principal consideration: Bruker has taken on additional debt to fund a series of acquisitions, so the debt-to-market-cap ratio should be verified against the 33% Sharia threshold at the time of investment. Subject to leverage verification, most major Sharia advisory boards classify Bruker as permissible with purification of small interest-income components.

⚠️ Concerns

•Debt-to-market-cap ratio should be verified against the 33% Sharia threshold at the time of investment — Bruker has funded a series of acquisitions partly with debt; this is the primary Sharia-screening consideration
•Bruker is an active acquirer — acquisition activity can affect leverage and goodwill, so the financial screen should be re-verified following material acquisitions
•Minor interest income on cash and short-term investment balances — purification of a small portion of dividends may be advisable
•Scientific instruments are sold into mixed-Sharia-profile end-markets (academic-research, pharmaceutical, biotechnology, applied-industrial, and clinical) — under standard Sharia screening methodology, the relevant industry classification is general-purpose scientific-instrument manufacturing rather than the look-through end-customer mix
•Earnings can be sensitive to research-funding cycles, pharmaceutical-and-biotech capital-spending, and foreign-exchange movements given significant international operations — these are business-cycle considerations rather than Sharia screen concerns
•Receivables-to-assets ratio should be checked against the preferred board's threshold at the time of investment